Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 08-2023 | 05-2023 | 02-2023 | 11-2022 | 08-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,571 | -79,824 | -61,188 | -47,486 | -20,991 |
| Depreciation Amortization | 776 | 2,370 | 1,937 | 1,343 | 691 |
| Other Working Capital | 1,713 | -1,195 | -2,934 | -2,327 | -3,420 |
| Other Operating Activity | 4,587 | 53,539 | 40,487 | 32,990 | 12,646 |
| Operating Cash Flow | $-4,495 | $-25,110 | $-21,698 | $-15,480 | $-11,074 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 895 | 0 | N/A | N/A |
| Common Stock Issued | 2,875 | 29,032 | 27,680 | 13,652 | 11,519 |
| Other Financing Activity | 1,144 | 0 | 897 | 200 | 0 |
| Financing Cash Flow | $4,019 | $29,927 | $28,577 | $13,852 | $11,519 |
| Beginning Cash Position | 9,048 | 4,231 | 4,231 | 4,231 | 4,231 |
| End Cash Position | 8,572 | 9,048 | 11,110 | 2,603 | 4,676 |
| Net Cash Flow | $-476 | $4,817 | $6,879 | $-1,628 | $445 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,495 | -25,110 | -21,698 | -15,480 | -11,074 |
| Free Cash Flow | -4,495 | -25,110 | -21,698 | -15,480 | -11,074 |